Stage

Divestiture

Total Raised

$695.98M

Investors Count

5

Deal Terms

4

Portfolio Exits

2

Funding, Valuation & Revenue

12 Fundings

NantHealth has raised $695.98M over 12 rounds.

NantHealth's latest funding round was a IPO for $91M on June 2, 2016.

NantHealth's valuation in June 2015 was $2,000M.

NantHealth's latest post-money valuation is from June 2016.

Sign up for a free demo to see NantHealth's valuations in June 2016 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/2/2016

IPO

$91M

$XXM

0

FY undefined

7

1/13/2016

Unattributed - IV

$52.5M

Undisclosed Investors

$XXM

0

FY undefined

1

10/14/2015

Unattributed - III

$0.2M

Undisclosed Investors

$XXM

0

FY undefined

1

9/18/2015

Unattributed - II

$XXM

$XXM

0

FY undefined

10

6/30/2015

Corporate Minority - III

$XXM

$2,000M

0

FY undefined

10

Date

6/2/2016

1/13/2016

10/14/2015

9/18/2015

6/30/2015

Round

IPO

Unattributed - IV

Unattributed - III

Unattributed - II

Corporate Minority - III

Amount

$91M

$52.5M

$0.2M

$XXM

$XXM

Investors

Undisclosed Investors

Undisclosed Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$2,000M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

7

1

1

10

10

Start free trial
New call-to-action

NantHealth Deal Terms

4 Deal Terms

NantHealth's deal structure is available for 4 funding rounds, including their IPO from June 02, 2016.

Round

IPO

Corporate Minority - III

Series B

Series A

Funding Date

$XXM

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

$XXM

Post-Money Valuation

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Corporate Minority - III

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

NantHealth Investors

5 Investors

NantHealth has 5 investors. Veradigm invested in NantHealth's Corporate Minority - III funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/30/2015

6/30/2015

1
Corporate Minority - III

Corporation

Illinois

00/00/0000

00/00/0000

Kuwait Investment Authority

Subscribe to see more

Sovereign Wealth Fund

Kuwait

00/00/0000

00/00/0000

Celgene

Subscribe to see more

Corporation

New Jersey

00/00/0000

00/00/0000

BlackBerry

Subscribe to see more

Corporation

Canada

00/00/0000

00/00/0000

Verizon Ventures

Subscribe to see more

Corporate Venture

New Jersey

First funding

6/30/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/30/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Kuwait Investment Authority

Celgene

BlackBerry

Verizon Ventures

Rounds

1
Corporate Minority - III

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Sovereign Wealth Fund

Corporation

Corporation

Corporate Venture

Location

Illinois

Kuwait

New Jersey

Canada

New Jersey

NantHealth Acquisitions

5 Acquisitions

NantHealth acquired 5 companies. Their latest acquisition was OpenNMS on July 27, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/27/2020

$XXM

Acquired

5

7/5/2017

Subscribe to see more

$XXM

Subscribe to see more

10

1/5/2016

Series D

Subscribe to see more

$XXM

$XXM

Subscribe to see more

10

7/16/2015

Subscribe to see more

$XXM

Subscribe to see more

10

2/21/2011

Subscribe to see more

$XXM

Subscribe to see more

0

Date

7/27/2020

7/5/2017

1/5/2016

7/16/2015

2/21/2011

Investment Stage

Series D

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Total Funding

$XXM

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

0

NantHealth Portfolio Exits

2 Portfolio Exits

NantHealth has 2 portfolio exits. Their latest portfolio exit was NantHealth - Connected Care Business on January 14, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/14/2020

Divestiture

NantHealth - Connected Care Business

$XXM

1

Divestiture

Subscribe to see more

$XXM

Subscribe to see more

10

Date

1/14/2020

Exit

Divestiture

Divestiture

Companies

NantHealth - Connected Care Business

Subscribe to see more

Valuation

$XXM

$XXM

Acquirer

Subscribe to see more

Sources

1

10

New call-to-action

Compare NantHealth to Competitors

G
Guidehealth

Guidehealth operates as a health services platform that focuses on value-based care within the healthcare sector. The company uses artificial intelligence (AI)-based protocols and virtual Healthguides to identify and support patients in need of care. Guidehealth serves health systems and clinical networks, employing a data-driven approach to improve care delivery and administrative efficiency. It was founded in 2023 and is based in Dallas, Texas.

Px HealthCare Logo
Px HealthCare

Px HealthCare is a digital health company that operates a health platform aimed at oncology. The company provides a digital health platform that incorporates patient experience and real-world data science to assist with clinical outcomes in cancer treatment. Px HealthCare serves the healthcare sector, concentrating on offering resources for cancer patient monitoring and support for clinicians. It was founded in 2012 and is based in London, England.

H
Health Data Analytics Institute

Health Data Analytics Institute focuses on healthcare, specializing in the quantification of health risks and the development of personalized care profiles. The company offers an analytic platform designed to inform healthcare actions, utilizing data assets and risk modeling methodologies validated through peer-reviewed research. It was founded in 2016 and is based in Dedham, Massachusetts.

P
Pearl Health

Pearl Health operates within the healthcare sector, focusing on value-based care models. The company provides technology, services, and financial tools for proactive patient care, healthcare cost reduction, and performance in value-based care for Medicare and Medicare Advantage. Pearl Health serves the healthcare industry, focusing on primary care providers and healthcare organizations. It was founded in 2020 and is based in New York, New York.

OncoHealth Logo
OncoHealth

OncoHealth operates as a digital health company that provides a platform for oncology value management and virtual cancer care. The platform includes nursing, mental health, nutrition, and resource navigation services for patients and healthcare providers. OncoHealth serves health plans, employers, providers, and patients in the cancer care ecosystem. It was founded in 2009 and is based in Atlanta, Georgia.

Vytalize Health Logo
Vytalize Health

Vytalize Health is a value-based care platform that focuses on transforming healthcare for independent primary care physicians. The company offers data-driven support and a virtual clinic to enhance patient care and facilitate physicians' participation in value-based care arrangements with Medicare. Vytalize Health primarily serves private practices, group practices, community health centers, and existing ACOs, aiming to improve patient outcomes and practice efficiency. It was founded in 2014 and is based in Hoboken, New Jersey.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.